1Yamauchi K, Yamada S, Morita K, et al. Comparative of short - term arLxiolytic potency of alprazolam and tandospirone in psychiatric outpatients with anxiety disorders [ J ]. Hum Psychophannacol, 2001,16(6) :459 -473.
2Oshima T,Kasuya Y,Terazawa E,et al. The anxiolytic effects of the 5 -hydroxytryptamine- 1A agonist tandospirone before otolaryngologic surgery[ J]. Anesth Analg,2001,95 (5) : 1214 -1216.
3Hashizume H, Takigawa M, Anxiety in allergy and atopie dermatitis [J]. Curr Opin Allergy Clin Immunol,2006,6(5) :335 -339.
4Yoshino T, Nisijima K, Katoh S,et al. Tandospirone potentiates the fluoxetine - induced increases in extracellular dopamine via 5 - HTIA receptors in the rat medial frontal cortex[J]. Neurochem Int,2002,40 (4) :355 -360.
5Yamada K, Yagi G, Kanba S. Clinical efficacy of tandoepirone augmentation in patients with major depressive disorder: a randomized controlled trial[J]. Clin Neuresci,2003,57(2) :183 -187.
6Masuda Y,Akagawa Y, Hishikawa Y. Effect of serotonin 1A agonist tandospimne on depression symptoms in senile patients with dementia [J]. Hum Psychopharmacol,2002,17(4) :191 - 193.
7Sato M, Murakami M. Treatment for irritable bowel syndrome - psychotrepic drugs,antidepressants and so on[ J]. Nippon Rinsho,2006, 64(8) :1495 -1500.
8Kinoshita Y, Hashimoto T, Kawamura A, et al. Effects of famotldlne, mosapride and tandospirone for treatment of functional dyspepsia[ J ]. Aliment Pharmacol Ther,2005,21 ( Suppl 2) :37 -41.
9Sta S, Mizukami K, Asada T. A preliminary open label study of 5 - HTIA partial agonist tandospirone for behaviound and psychological associated with dementia[ J]. Int J Neuropsychophsrmacol,2006,3 : 1
10Yasuno F. Hippocampal serotonin 1A receptor and memory function [ J]. Seishin Shlnkeigaku Zasshi,2004,106(10) :1314 - 1322.
